Remove Compliance Remove Finance Remove Innovation Remove Pharmaceuticals
article thumbnail

Using Supply Chains to Grow Your Business

Harvard Business Review

One result is that they keep their cards close to their chests about what they are looking for (at first), while expecting you to reveal everything – your finances, pricing, ownership, human resources, production processes, quality assurance, customer service procedures, KPIs, and existing customers.

article thumbnail

How Merck Is Trying to Keep Disrupters at Bay

Harvard Business Review

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Questions Executives Should Ask About 3D Printing

Harvard Business Review

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Innovation, customization, speed, and location are also among the opportunities it offers. How could digital printing improve your innovation, product development, and speed to market?

article thumbnail

The Internet of Things Will Change Your Company, Not Just Your Products

Harvard Business Review

So instead of creating another pill dispenser, it launched a compliance-enhancing system. In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers.